Therapy for metastatic ESFT: is it time to ask new questions?
Snyder
Kristen M
KM
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892, USA.
Mackall
Crystal L
CL
D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000627:therapeutic use*; D001859:Bone Neoplasms / Q000473:pathology; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D015337:Multicenter Studies as Topic; D018242:Neuroectodermal Tumors, Primitive / Q000188:drug therapy / Q000556:secondary / Q000601:surgery; D036102:Peripheral Blood Stem Cell Transplantation; D010865:Pilot Projects; D012512:Sarcoma, Ewing / Q000188:drug therapy / Q000556:secondary* / Q000601:surgery; D014182:Transplantation, Autologous; D016896:Treatment Outcome
D018906:Antineoplastic Agents, Alkylating